The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
Open accessAbstract
The dysmetabolic iron overload syndrome (DIOS) is now a frequent finding in the general population, as is detected in about one third of patients with nonalcoholic fatty liver disease (NAFLD) and the metabolic syndrome. The pathogenesis is related to altered regulation of iron transport associated with steatosis, insulin resistance, and subclinical inflammation, often in the presence of predisposing genetic factors. Evidence is accumulating that excessive body iron plays a causal role in insulin resistance through still undefined mechanisms that probably involve a reduced ability to burn carbohydrates and altered function of adipose tissue. Furthermore, DIOS may facilitate the evolution to type 2 diabetes by altering beta-cell function, the progression of cardiovascular disease by contributing to the recruitment and activation of macrophages within arterial lesions, and the natural history of liver disease by inducing oxidative stress in hepatocytes, activation of hepatic stellate cells, and malignant transformation by promotion of cell growth and DNA damage. Based on these premises, the association among DIOS, metabolic syndrome, and NAFLD is being investigated as a new risk factor to predict the development of overt cardiovascular and hepatic diseases, and possibly hepatocellular carcinoma, but most importantly, represents also a treatable condition. Indeed, iron depletion, most frequently achieved by phlebotomy, has been shown to decrease metabolic alterations and liver enzymes in controlled studies in NAFLD. Additional studies are warranted to evaluate the potential of iron reductive therapy on hard clinical outcomes in patients with DIOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581 · cited 1×
“In particular, both are characterized by (1) the presence of metabolic alterations typical of MetS [21,29,35]; (2) the presence of fatty liver [29]; (3) hyperferritinemia with normal or only slightly elevated transferrin saturation, reflecting physiological upregulation of hepcidin in response to increased iron stores…”
BackgroundReactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 2×
“Reactive oxygen species (ROS) have been implicated in IR pathogenesis on the basis of two types of indirect evidence: (1) an association of oxidative stress markers with obesity and T2D [66,67] and (2) evidence that factors that increase ROS in adipocytes induce IR [65,68].”
BackgroundLong-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 1×
“In obese mice, deletion of adiponectin receptors induces inflammation, oxidative stress, and IR, whereas adiponectin overexpression improves IR and reverts the diabetic phenotype [82].”
BackgroundHepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.
Halaas, J. L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D. A., & Friedman, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8878 · Cited by 1,033
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Adiponectin Expression From Human Adipose Tissue
Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., & Ranganathan, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1779 · Cited by 875
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., Dawkins, F. W., Acton, R. T., Harris, E. L., Gordeuk, V. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041534 · Cited by 775
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756 · cited 2×
“It has been reported that in DIOS iron absorption is decreased and hepcidin, the hormone that acts by decreasing intestinal iron absorption and recycling from macrophages [33], is increased compared to healthy controls, indicating that iron compartmentalization in monocytes is likely related to a relatively preserved…”
BackgroundCross-Talk Between Iron Metabolism and Diabetes
Fernández-Real, J. M., López-Bermejo, A., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2348 · Cited by 704
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP
Lin, J., Yang, R., Tarr, P. T., Wu, P.-H., Handschin, C., Li, S., Yang, W., Pei, L., Uldry, M., Tontonoz, P., et al. (2005) · Cell · doi:10.1016/j.cell.2004.11.043 · Cited by 625
Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women
Jiang, R. (2004) · JAMA · doi:10.1001/jama.291.6.711 · Cited by 598
Lee, K. S., Buck, M., Houglum, K., & Chojkier, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118304 · Cited by 539
Insulin resistance–associated hepatic iron overload
Mendler, M.-H., Turlin, B., Moirand, R., Jouanolle, A.-M., Sapey, T., Guyader, D., le Gall, J.-Y., Brissot, P., David, V., & Deugnier, Y. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70401-4 · Cited by 501
Adipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 471
Saxena, N. K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., & Anania, F. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3075 · Cited by 469
Serum Ferritin and Risk of the Metabolic Syndrome in U.S. Adults
Jehn, M., Clark, J. M., & Guallar, E. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2422 · Cited by 443
Bugianesi, E., Manzini, P., D'Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A., Marchesini, G., & Rizzetto, M. (2004) · Hepatology · doi:10.1002/hep.20023 · Cited by 440
Diabetes and serum ferritin concentration among U.S. adults.
Ford, E. S., & Cogswell, M. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1978 · Cited by 419
Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men
Urakawa, H., Katsuki, A., Sumida, Y., Gabazza, E. C., Murashima, S., Morioka, K., Maruyama, N., Kitagawa, N., Tanaka, T., Hori, Y., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030202 · Cited by 416
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Zenari, L., Cigolini, M., Falezza, G., & Arcaro, G. (2006) · Diabetes Care · doi:10.2337/dc06-0135 · Cited by 401
Day, C. P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.017 · Cited by 395
Nonalcoholic fatty liver disease and mitochondrial dysfunction
Wei, Y., Rector, R. S., Thyfault, J. P., & Ibdah, J. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.193 · Cited by 369
Nelson, J. E., Wilson, L., Brunt, E. M., Yeh, M. M., Kleiner, D. E., Unalp-Arida, A., & Kowdley, K. V. (2011) · Hepatology · doi:10.1002/hep.24038 · Cited by 356
Iron imports. IV. Hepcidin and regulation of body iron metabolism
Ganz, T., & Nemeth, E. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2005 · Cited by 347 · cited 1×
“Indeed, ID decreased atherogenesis in experimental models [108,113], blood donation was associated with lower risk of myocardial infarction [5] and phlebotomy slowed the progression of vascular disease [114,115], whereas the lack of association between HFE mutations with vascular damage might be explained by the decre…”
BackgroundBlood Letting in High-Ferritin Type 2 Diabetes
Fernández-Real, J. M., Peñarroja, G., Castro, A., García-Bragado, F., Hernández-Aguado, I., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1000 · Cited by 334
Serum Ferritin as a Component of the Insulin Resistance Syndrome
Fernández-Real, J.-M., Ricart-Engel, W., Arroyo, E., Balançá, R., Casamitjana-Abella, R., Cabrero, D., Fernández-Castañer, M., & Soler, J. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.62 · Cited by 328
Nose, Y., Kim, B.-E., & Thiele, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.08.009 · Cited by 325
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Polyzos, S. A., Toulis, K. A., Goulis, D. G., Zavos, C., & Kountouras, J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.09.003 · Cited by 311
ER Stress Controls Iron Metabolism Through Induction of Hepcidin
Vecchi, C., Montosi, G., Zhang, K., Lamberti, I., Duncan, S. A., Kaufman, R. J., & Pietrangelo, A. (2009) · Science · doi:10.1126/science.1176639 · Cited by 310 · cited 1×
“It is thus possible that the coexistence of multiple genetic variants contributes to DIOS [13,14,27,30], and it could be speculated that AAT modulate iron metabolism by inducing ER stress [58].”
BackgroundRuddell, R. G., Hoang‐Le, D., Barwood, J. M., Rutherford, P. S., Piva, T. J., Watters, D. J., Santambrogio, P., Arosio, P., & Ramm, G. A. (2009) · Hepatology · doi:10.1002/hep.22716 · Cited by 298
Valenti, L., Fracanzani, A. L., Dongiovanni, P., Bugianesi, E., Marchesini, G., Manzini, P., Vanni, E., & Fargion, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01192.x · Cited by 290
Self-citationValenti, L., Fracanzani, A. L., Dongiovanni, P., Santorelli, G., Branchi, A., Taioli, E., Fiorelli, G., & Fargion, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.31065 · Cited by 289
Self-citationValenti, L., Fracanzani, A. L., Bugianesi, E., Dongiovanni, P., Galmozzi, E., Vanni, E., Canavesi, E., Lattuada, E., Roviaro, G., Marchesini, G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.013 · Cited by 281
Self-citationActivation of SOCS-3 by Resistin
Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J., & Lazar, M. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1569-1575.2005 · Cited by 281
Autocrine formation of hepcidin induces iron retention in human monocytes
Theurl, I., Theurl, M., Seifert, M., Mair, S., Nairz, M., Rumpold, H., Zoller, H., Bellmann-Weiler, R., Niederegger, H., Talasz, H., et al. (2008) · Blood · doi:10.1182/blood-2007-05-090019 · Cited by 275
Forouhi, N. G., Harding, A. H., Allison, M., Sandhu, M. S., Welch, A., Luben, R., Bingham, S., Khaw, K. T., & Wareham, N. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0604-5 · Cited by 266
Cooksey, R. C., Jouihan, H. A., Ajioka, R. S., Hazel, M. W., Jones, D. L., Kushner, J. P., & McClain, D. A. (2004) · Endocrinology · doi:10.1210/en.2004-0392 · Cited by 253
Chitturi, S., Weltman, M., Farrell, G. C., McDonald, D., Liddle, C., Samarasinghe, D., Lin, R., Abeygunasekera, S., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33892 · Cited by 247
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
Facchini, F. S., Hua, N. W., & Stoohs, R. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32403 · Cited by 233
Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., Baron, J. A., Dalman, R. L., Malenka, D. J., Ozaki, C. K., & Lavori, P. W. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn209 · Cited by 230
Coronary Heart Disease and Iron Status: Meta-Analyses of Prospective Studies
Danesh, J., & Appleby, P. (1999) · Circulation · doi:10.1161/01.cir.99.7.852 · Cited by 226
Takehara, T., Tatsumi, T., Suzuki, T., Rucker, E. B., Hennighausen, L., Jinushi, M., Miyagi, T., Kanazawa, Y., & Hayashi, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.019 · Cited by 225
Prevalence of Body Iron Excess in the Metabolic Syndrome
Bozzini, C., Girelli, D., Olivieri, O., Martinelli, N., Bassi, A., De Matteis, G., Tenuti, I., Lotto, V., Friso, S., Pizzolo, F., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2061 · Cited by 224
A Role for Low Hepatic Copper Concentrations in Nonalcoholic Fatty Liver Disease
Aigner, E., Strasser, M., Haufe, H., Sonnweber, T., Hohla, F., Stadlmayr, A., Solioz, M., Tilg, H., Patsch, W., Weiss, G., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.170 · Cited by 221
Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease
Sanyal, A. J. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0084 · Cited by 216 · cited 1×
“As mentioned above, unbalanced oxidative stress is considered a trigger of NAFLD [46], and SOD1, one of the enzymes counteracting oxidative stress, depends on adequate Cu availability [47].”
BackgroundCarotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
Fracanzani, A. L., Burdick, L., Raselli, S., Pedotti, P., Grigore, L., Santorelli, G., Valenti, L., Maraschi, A., Catapano, A., & Fargion, S. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.08.041 · Cited by 209
Self-citationSalonen, J. T., Tuomainen, T.-P., Salonen, R., Lakka, T. A., & Nyyssonen, K. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009669 · Cited by 199
del Giudice, E. M., Santoro, N., Amato, A., Brienza, C., Calabrò, P., Wiegerinck, E. T., Cirillo, G., Tartaglione, N., Grandone, A., Swinkels, D. W., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1361 · Cited by 197
Musso, G., Gambino, R., Biroli, G., Carello, M., Faga, E., Pacini, G., De Michieli, F., Cassader, M., Durazzo, M., Rizzetto, M., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00297.x · Cited by 192
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease
Aigner, E., Theurl, I., Theurl, M., Lederer, D., Haufe, H., Dietze, O., Strasser, M., Datz, C., & Weiss, G. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1374 · Cited by 190
Leptin Increases the Expression of the Iron Regulatory Hormone Hepcidin in HuH7 Human Hepatoma Cells
Chung, B., Matak, P., McKie, A. T., & Sharp, P. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.11.2366 · Cited by 188
A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance
Smith, S. R., Bai, F., Charbonneau, C., Janderová, L., & Argyropoulos, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1611 · Cited by 188
Sorrentino, P., D’Angelo, S., Ferbo, U., Micheli, P., Bracigliano, A., & Vecchione, R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.011 · Cited by 183
Iron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice
Lee, T.-S., Shiao, M.-S., Pan, C.-C., & Chau, L.-Y. (1999) · Circulation · doi:10.1161/01.cir.99.9.1222 · Cited by 179
Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., Baron, J. A., Dalman, R. L., Malenka, D. J., Ozaki, C. K., & Lavori, P. W. (2007) · JAMA · doi:10.1001/jama.297.6.603 · Cited by 179
Steatosis Is a Cofactor in Liver Injury in Hemochromatosis
Powell, E. E., Ali, A., Clouston, A. D., Dixon, J. L., Lincoln, D. J., Purdie, D. M., Fletcher, L. M., Powell, L. W., & Jonsson, J. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.015 · Cited by 176
Copper Availability Contributes to Iron Perturbations in Human Nonalcoholic Fatty Liver Disease
Aigner, E., Theurl, I., Haufe, H., Seifert, M., Hohla, F., Scharinger, L., Stickel, F., Mourlane, F., Weiss, G., & Datz, C. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.007 · Cited by 169
Dongiovanni, P., Valenti, L., Ludovica Fracanzani, A., Gatti, S., Cairo, G., & Fargion, S. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070097 · Cited by 169
Self-citationCooksey, R. C., Jones, D., Gabrielsen, S., Huang, J., Simcox, J. A., Luo, B., Soesanto, Y., Rienhoff, H., Dale Abel, E., & McClain, D. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00022.2010 · Cited by 168
Otogawa, K., Kinoshita, K., Fujii, H., Sakabe, M., Shiga, R., Nakatani, K., Ikeda, K., Nakajima, Y., Ikura, Y., Ueda, M., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060441 · Cited by 162
Wrede, C. E., Buettner, R., Bollheimer, L. C., Schölmerich, J., Palitzsch, K.-D., & Hellerbrand, C. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02083 · Cited by 161
Iron Stores, Blood Donation, and Insulin Sensitivity and Secretion
Fernández‐Real, J. M., López‐Bermejo, A., & Ricart, W. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046847 · Cited by 158
Kitade, M., Yoshiji, H., Kojima, H., Ikenaka, Y., Noguchi, R., Kaji, K., Yoshii, J., Yanase, K., Namisaki, T., Asada, K., et al. (2006) · Hepatology · doi:10.1002/hep.21338 · Cited by 157
Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability
Sullivan, J. L. (2007) · Experimental Biology and Medicine · doi:10.3181/0703-mr-54 · Cited by 156
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Kim, C., Kim, H., Bae, S. J., Park, J., & Lee, K.-U. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.007 · Cited by 152
Huang, J., Jones, D., Luo, B., Sanderson, M. J., Soto, J. E., Abel, E. D., Cooksey, R. C., & McClain, D. A. (2010) · Diabetes · doi:10.2337/db10-0593 · Cited by 151
Turlin, B., Mendler, M. H., Moirand, R., Guyader, D., Guillygomarc’h, A., & Deugnier, Y. (2001) · American Journal of Clinical Pathology · doi:10.1309/wwne-kw2c-4ktw-ptj5 · Cited by 145
Increased risk of chronic liver failure in adults with heterozygous α-antitrypsin deficiency
Graziadei, I. W., Joseph, J. J., Wiesner, R. H., Therneau, T. M., Batts, K. P., & Porayko, M. K. (1998) · Hepatology · doi:10.1002/hep.510280421 · Cited by 144
Modulation of Resistin Expression by Retinoic Acid and Vitamin A Status
Felipe, F., Bonet, M. L., Ribot, J., & Palou, A. (2004) · Diabetes · doi:10.2337/diabetes.53.4.882 · Cited by 123
Nelson, J. E., Bhattacharya, R., Lindor, K. D., Chalasani, N., Raaka, S., Heathcote, J., Miskovsky, E. P., Shaffer, E. A., Rulyak, S. J., & Kowdley, K. V. (2007) · Hepatology · doi:10.1002/hep.21742 · Cited by 122
Iron activates NF-κB in Kupffer cells
She, H., Xiong, S., Lin, M., Zandi, E., Giulivi, C., & Tsukamoto, H. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00108.2002 · Cited by 121
Serfaty, L., Chazouillères, O., Poujol‐Robert, A., Morand‐Joubert, L., Dubois, C., Chrétien, Y., Poupon, R. E., Petit, J., & Poupon, R. Y. (1997) · Hepatology · doi:10.1002/hep.510260334 · Cited by 119
Transferrin and iron induce insulin resistance of glucose transport in adipocytes
Green, A., Basile, R., & Rumberger, J. M. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.015 · Cited by 116
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload
Barisani, D., Pelucchi, S., Mariani, R., Galimberti, S., Trombini, P., Fumagalli, D., Meneveri, R., Nemeth, E., Ganz, T., & Piperno, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.011 · Cited by 112
Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin
Palanivel, R., & Sweeney, G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.011 · Cited by 111
Fargion, S. R., Dongiovanni, P., Guzzo, A. C., Colombo, S. F., Valenti, L. V. C., & Fracanzani, A. L. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02599.x · Cited by 108
Self-citationIron Overload Is Associated with Hepatic Oxidative Damage to DNA in Nonalcoholic Steatohepatitis
Fujita, N., Miyachi, H., Tanaka, H., Takeo, M., Nakagawa, N., Kobayashi, Y., Iwasa, M., Watanabe, S., & Takei, Y. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0725 · Cited by 107
Chen, Y., Chau, L., Chen, J., & Lin, S. (2008) · Diabetes Care · doi:10.2337/dc07-2126 · Cited by 104
Jouihan, H. A., Cobine, P. A., Cooksey, R. C., Hoagland, E. A., Boudina, S., Abel, E. D., Winge, D. R., & McClain, D. A. (2008) · Molecular Medicine · doi:10.2119/2007-00114.jouihan · Cited by 103
Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats
Minamiyama, Y., Takemura, S., Kodai, S., Shinkawa, H., Tsukioka, T., Ichikawa, H., Naito, Y., Yoshikawa, T., & Okada, S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2009 · Cited by 102
Valenti, L. V. C., Swinkels, D. W., Burdick, L., Dongiovanni, P., Tjalsma, H., Motta, B. M., Bertelli, C., Fatta, E., Bignamini, D., Rametta, R., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.01.003 · Cited by 100
Self-citationValenti, L. V. C., Dongiovanni, P., Fracanzani, A. L., Santorelli, G., Fatta, E., Bertelli, C., Taioli, E., Fiorelli, G., & Fargion, S. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00025-2 · Cited by 98
Self-citationValenti, L. V. C., Dongiovanni, P., Motta, B. M., Swinkels, D. W., Bonara, P., Rametta, R., Burdick, L., Frugoni, C., Fracanzani, A. L., & Fargion, S. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.214858 · Cited by 96
Self-citationα1‐Antitrypsin mutations in NAFLD
Valenti, L. V. C., Dongiovanni, P., Piperno, A., Fracanzani, A. L., Maggioni, M., Rametta, R., Loria, P., Casiraghi, M. A., Suigo, E., Ceriani, R., et al. (2006) · Hepatology · doi:10.1002/hep.21329 · Cited by 94
Self-citationValenti, L. V. C., Conte, D., Piperno, A., Dongiovanni, P., Fracanzani, A. L., Fraquelli, M., Vergani, A., Gianni, C., Carmagnola, L., & Fargion, S. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019588 · Cited by 93
Self-citationVenesection therapy of insulin resistance-associated hepatic iron overload
Guillygomarc’h, A., Mendler, M. H., Moirand, R., Lainé, F., Quentin, V., David, V., Brissot, P., & Deugnier, Y. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00147-7 · Cited by 91
Acton, R. T., Barton, J. C., Passmore, L. V., Adams, P. C., Speechley, M. R., Dawkins, F. W., Sholinsky, P. D., Reboussin, D. M., McLaren, G. D., Harris, E. L., et al. (2006) · Diabetes Care · doi:10.2337/dc05-1592 · Cited by 90
Ruivard, M., Lainé, F., Ganz, T., Olbina, G., Westerman, M., Nemeth, E., Rambeau, M., Mazur, A., Gerbaud, L., Tournilhac, V., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.029 · Cited by 89 · cited 1×
“It has been reported that in DIOS iron absorption is decreased and hepcidin, the hormone that acts by decreasing intestinal iron absorption and recycling from macrophages [33], is increased compared to healthy controls, indicating that iron compartmentalization in monocytes is likely related to a relatively preserved…”
BackgroundLuque‐Ramírez, M., Álvarez‐Blasco, F., Botella-Carretero, J. I., Sánchón, R., Millán, J. L. S., & Escobar-Morreale, H. F. (2007) · Diabetes Care · doi:10.2337/dc07-0642 · Cited by 89
Fargion, S. R., Valenti, L. V. C., Dongiovanni, P., Scaccabarozzi, A., Fracanzani, A. L., Taioli, E., Mattioli, M., Sampietro, M., & Fiorelli, G. (2001) · Blood · doi:10.1182/blood.v97.12.3707 · Cited by 87
Self-citationValenti, L. V. C., Moscatiello, S., Vanni, E., Fracanzani, A. L., Bugianesi, E., Fargion, S. R., & Marchesini, G. (2010) · QJM · doi:10.1093/qjmed/hcq170 · Cited by 87
Self-citationRole of hepatic iron in non‐alcoholic steatohepatitis
Sumida, Y., Yoshikawa, T., & Okanoue, T. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00442.x · Cited by 77
Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic Carcinogenesis
Dongiovanni, P., Fracanzani, A. L., Cairo, G., Megazzini, C., Gatti, S., Rametta, R., Fargion, S. R., & Valenti, L. V. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090249 · Cited by 75
Self-citationBrown, K. E., Dennery, P. A., Ridnour, L. A., Fimmel, C. J., Kladney, R. D., Brunt, E. M., & Spitz, D. R. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00832.x · Cited by 70
Pankow, J. S., Boerwinkle, E., Adams, P. C., Güallar, E., Leiendecker‐Foster, C., Rogowski, J., & Eckfeldt, J. H. (2008) · Translational research · doi:10.1016/j.trsl.2008.05.005 · Cited by 70
Body Iron Stores Are Increased in Overweight and Obese Women With Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque‐Ramírez, M., Álvarez‐Blasco, F., Botella-Carretero, J. I., Sancho, J., & Millán, J. L. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2042 · Cited by 65
Valenti, L. V. C., Canavesi, E., Galmozzi, E., Dongiovanni, P., Rametta, R., Maggioni, P., Maggioni, M., Fracanzani, A. L., & Fargion, S. R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.023 · Cited by 64
Self-citationLapenna, D., Pierdomenico, S. D., Ciofani, G., Ucchino, S., Neri, M., Giamberardino, M. A., & CUCCURULLO, F. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.014 · Cited by 63
Relationship between TNF‐α and iron metabolism in differentiating human monocytic THP‐1 cells
Scaccabarozzi, A., Arosio, P., Weiß, G., Valenti, L. V. C., Dongiovanni, P., Fracanzani, A. L., Mattioli, M., Levi, S., Fiorelli, G., & Fargion, S. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02280.x · Cited by 62
Self-citationLin, H., Yu, C.-H., Jen, C.-Y., Cheng, C., Chou, Y., Chang, C.-C., & Juan, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090789 · Cited by 59
Fernández‐Real, J. M., Moreno‐Navarrete, J. M., Chico, B., López‐Bermejo, A., & Ricart, W. (2007) · Diabetes Care · doi:10.2337/dc06-1581 · Cited by 59
Ramos, P., Guy, E. C., Chen, N., Proenca, C. C., Gardenghi, S., Casu, C., Follenzi, A., van Rooijen, N., Grady, R. W., de Sousa, M. A. B., et al. (2010) · Blood · doi:10.1182/blood-2010-09-307462 · Cited by 58
Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats
Borel, M. J., Beard, J. L., & Farrell, P. A. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.3.e380 · Cited by 58
Riva, A., Trombini, P., Mariani, R., Salvioni, A., Coletti, S., Bonfadini, S., Paolini, V., Pozzi, M., Facchetti, R., Bovo, G., et al. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4745 · Cited by 57
Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in β-thalassemia
Maioli, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06095-4 · Cited by 56
The Kuopio Ischaemic Heart Disease Risk Factor Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_36 · Cited by 51
Piperno, A., Vergani, A., Salvioni, A., Trombini, P., Viganò, M., Riva, A., Zoppo, A., Boari, G., & Mancia, G. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0988.x · Cited by 50
Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death
İmeryüz, N., Tahan, V., Sonsuz, A., Eren, F., Uraz, S., Yüksel, M., Akpulat, S., Özçelik, D., Haklar, G., Çelikel, Ç., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.018 · Cited by 49
Effects of iron overload in a rat nutritional model of non‐alcoholic fatty liver disease
Kirsch, R., Sijtsema, H. P., Tlali, M., Marais, A. D., & Hall, P. D. L. Μ. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01329.x · Cited by 49
Hemochromatosis gene (HFE) mutations and cancer risk
Fargion, S. R., Valenti, L. V. C., & Fracanzani, A. L. (2010) · Hepatology · doi:10.1002/hep.23541 · Cited by 46
Self-citationEquitani, F., Fernández‐Real, J. M., MENICHELLA, G., Koch, M., Calvani, M., Nobili, V., Mingrone, G., & Manco, M. (2007) · Diabetes Care · doi:10.2337/dc07-0939 · Cited by 46
Insulin Sensitivity and Liver Fat: Role of Iron Load
Haap, M. M., Machann, J., von Friedeburg, C., Schick, F., Stefan, N., Schwenzer, N. F., Fritsche, A., Häring, H. U., & Thamer, C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2682 · Cited by 45
Huang, W., Dedousis, N., & O'Doherty, R. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01449.2006 · Cited by 45
Fernández‐Real, J. M., Moreno‐Navarrete, J. M., & Ricart, W. (2008) · Diabetes · doi:10.2337/db08-0041 · Cited by 45
Increased Glucose Disposal and AMP-dependent Kinase Signaling in a Mouse Model of Hemochromatosis
Huang, J., Gabrielsen, J. S., Cooksey, R. C., Luo, B., Boros, L. G., Jones, D. L., Jouihan, H. A., Soesanto, Y., Knecht, L., Hazel, M. W., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703625200 · Cited by 42
Valenti, L. V. C., Fracanzani, A. L., & Fargion, S. R. (2003) · Gastroenterology · doi:10.1053/gast.2003.50130 · Cited by 42
Self-citationManco, M., Alisi, A., Real, J.-M. F., Equitani, F., Vito, R. D., Valenti, L. V. C., & Nobili, V. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.007 · Cited by 41
Self-citationAso, Y., Takebayashi, K., Wakabayashi, S., Momobayashi, A., Sugawara, N., Terasawa, T., Naruse, R., Hara, K., Suetsugu, M., Morita, K., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.09.008 · Cited by 40
Pelucchi, S., Mariani, R., Salvioni, A., Bonfadini, S., Riva, A., Bertola, F., Trombini, P., & Piperno, A. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00950.x · Cited by 40
Ku, B. J., Kim, S.-Y., Lee, T., & Park, K. S. (2009) · Disease Markers · doi:10.1155/2009/931082 · Cited by 34
Efficacy of Antioxidant Treatment in Reducing Resistin Serum Levels: A Randomized Study
Bo, S., Ciccone, G., Durazzo, M., Gambino, R., Massarenti, P., Baldi, I., Lezo, A., Tiozzo, E., Pauletto, D., Cassader, M., et al. (2007) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0020017 · Cited by 33
Regulation of glucose transport and GLUT-1 expression by iron chelators in muscle cells in culture
Potashnik, R., Kozlovsky, N., Ben-Ezra, S., Rudich, A., & Bashan, N. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.6.e1052 · Cited by 31
Adams, P. C., Pankow, J. S., Barton, J. C., Acton, R. T., Leiendecker-Foster, C., McLaren, G. D., Speechley, M. R., & Eckfeldt, J. H. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.813089 · Cited by 31
Attenuation of acute and chronic liver injury in rats by iron-deficient diet
Otogawa, K., Ogawa, T., Shiga, R., Nakatani, K., Ikeda, K., Nakajima, Y., & Kawada, N. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00735.2007 · Cited by 30
HFE mutations and risk of coronary heart disease in middle‐aged women
van der A, D. L., Peeters, P. H. M., Grobbee, D. E., Roest, M., Marx, J. J. M., Voorbij, H. A. M., & van der Schouw, Y. T. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01711.x · Cited by 28
Lee, F., Jen, C.-Y., Chang, C., Chou, Y., Lin, H., Chou, C., & Juan, S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22192 · Cited by 15
Neri, S., Pulvirenti, D., Signorelli, S. S., Ignaccolo, L., Tsami, A., Mauceri, B., Misseri, M., Interlandi, D., Cutuli, N., & Castellino, P. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01474.x · Cited by 12
HFE gene mutations increase the risk of coronary heart disease in women
Silva, M. C. P., Njajou, O. T., Alizadeh, B. Z., Albert Hofman, D., Witteman, J. C. M., van Duijn, C. M., & Janssens, A. C. J. W. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9489-6 · Cited by 12
Cited by
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Masarone, M., Rosato, V., Dallio, M., Gravina, A. G., Aglitti, A., Loguercio, C., Federico, A., & Persico, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9547613 · Cited by 648
Simcox, J. A., & McClain, D. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.007 · Cited by 545
Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases
Sonnweber, T., Pizzini, A., Nairz, M., Weiss, G., & Tancevski, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113285 · Cited by 440
Mechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 429
Obesity as an emerging risk factor for iron deficiency
Aigner, E., Feldman, A., & Datz, C. (2014) · Nutrients · doi:10.3390/nu6093587 · Cited by 328
Metadata
- Authors
- Dongiovanni, P., Fracanzani, A. L., Fargion, S., & Valenti, L.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 55
- Issue
- 4
- Pages
- 920-932
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2116488121
- Cited by
- 362
- References
- 148
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.